Deep search
Web
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US Invests $590 Million to Fast-Track Vaccine Development
Moderna Is Getting $590 Million From the U.S. to Accelerate a Bird Flu Vaccine
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Bird Flu: US Invests $590 Million to Fast-Track Vaccine Development
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.
Moderna gets $590M from US government for bird flu vaccine
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats. Others, including GSK and Pfizer, are also at work on similar shots.
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to
Moderna Awarded $590 Million for Bird Flu Vaccine Development
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.
U.S. pays $590 million to Moderna to speed up development of bird flu vaccine
The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
Moderna Stock Jumps as Biotech Gets $590M From US To Develop Bird-Flu Vaccine
Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.The biotech firm's mRNA-1018 candidate posted positive results in a Phase 1/2 study launched in 2023.
6d
on MSN
How effective is the flu vaccine amid California ‘quad-demic’? Is it too late to get shots?
The flu vaccine is generally about 40% effective at completely preventing influenza, according to Blumberg. The flu vaccine ...
2d
on MSN
US awards Moderna $590 million for bird flu vaccine development
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Hosted on MSN
10h
MoH: Flu vaccine brings down deaths by 70%
The Ministry of Health said that there has been a 70 percent reduction in cumulative deaths caused by seasonal influenza compared to the same period last year. The ministry attributed this mainly to ...
Medscape
6d
Seasonal Flu Shot: First Defense Against an Eventful Avian Influenza Pandemic
Seasonal influenza vaccines triggered protective immune responses against the H5N1 avian influenza virus primarily in younger ...
KALW
5d
How would RFK Jr. handle bird flu? His record on vaccines has experts on edge
Trump's pick for health secretary has a record of attacking vaccines. In fact he's even taken direct aim at bird flu shots.
4d
on MSN
Moderna Gets $590 Million in Federal Funding for Bird Flu Vaccine
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Moderna
United States Department of Health and Human Services
Feedback